Business Context and Reporting Period
This Form 8-K, filed by 8i Acquisition 2 Corp. on November 24, 2021, reports the effectiveness of its IPO registration statement on November 22, 2021, and the closing of its initial public offering and related private placement on November 24, 2021. The request identifies EUDA Health Holdings Ltd.; however, the filing itself concerns 8i Acquisition 2 Corp. and does not mention EUDA Health Holdings Ltd.
Key Financial and Capital Markets Metrics
- The IPO initially consisted of 7,500,000 units priced at $10.00 per unit, generating $75.0 million of gross proceeds.
- The underwriters fully exercised their 1,125,000-unit over-allotment option, resulting in total IPO issuance of 8,625,000 units and gross IPO proceeds of $86.25 million.
- Each unit included one ordinary share, one warrant to purchase one-half of an ordinary share, and one right to receive one-tenth of an ordinary share upon completion of an initial business combination.
- The company also issued 292,250 private units to its chief executive officer at $10.00 per unit, generating $2.9225 million of proceeds.
- As of November 24, 2021, $86.25 million of net IPO and private placement proceeds had been deposited into a trust account for public shareholders. The filing text does not provide operating revenue, profit, cash flow, margins, debt, or liquidity metrics beyond these financing proceeds.
Material Changes Versus the Prior Comparable Period
No prior-period operating or financial results are presented. The material change was the completion of the IPO, full exercise of the over-allotment option, private placement, and funding of the shareholder trust account.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- The filing does not provide financial guidance or management outlook.
- The company is a blank-check acquisition vehicle and had not reported an operating business or completed an initial business combination in this filing.
- The private units and underlying securities are subject to transfer restrictions until completion of the initial business combination, subject to limited exceptions.
- The company entered into customary SPAC agreements, including underwriting, warrant, rights, escrow, trust, registration rights, administrative services, and shareholder letter agreements.
- An audited balance sheet reflecting the IPO and private placement proceeds was expected to be filed within four business days after the IPO closing.
Investor Verification Items
- Verify the issuer identity, because the filing is for 8i Acquisition 2 Corp., not EUDA Health Holdings Ltd.
- Review the audited post-closing balance sheet and trust-account disclosures when filed.
- Confirm the terms, exercise conditions, and potential dilution from the warrants, rights, private units, and underwriter unit purchase option.
- Review the deadline and proposed terms for the company’s initial business combination, which are not specified in the provided filing text.
- Assess the transfer restrictions, redemption rights, escrow arrangements, and other terms contained in the filed exhibits.